A study evaluating PRO 1286
Latest Information Update: 16 Feb 2024
At a glance
- Drugs PRO 1286 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
Most Recent Events
- 16 Feb 2024 New trial record
- 13 Feb 2024 According to a ProfoundBio media release, trial is anticipated to begin in 2024.